Evaluating the Efficacy of Erector Spinae Block in Routine Hip Arthroscopy

NCT ID: NCT04917510

Last Updated: 2021-06-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-07-31

Study Completion Date

2023-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this project is to evaluate the efficacy of preoperative erector spinae blocks in arthroscopic hip surgery. This will be a prospective randomized controlled trial.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this project is to evaluate the efficacy of preoperative erector spinae blocks in arthroscopic hip surgery. This will be a prospective randomized controlled trial. The control group will not receive a preoperative block prior to surgery, but will receive local anesthetic at the surgical site at the conclusion of the surgery. The study group will receive a preoperative block and local anesthetic. The primary outcomes will be pain levels and opioid consumption in the post-operative care unit. The secondary outcomes will be pain levels and opioid consumption post-operatively, and functional outcome measures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Disease Postoperative Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients will be randomized to either the study group or control group prior to undergoing surgery
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Erector spinae block will be performed after general anesthesia has been induced. Patients will be unaware which arm of the study they are in.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Will not receive erector spinae block. Will be administered 30 mL of 0.5% Marcaine w/ epinephrine as a local block at the surgical site at the conclusion of the procedure.

Group Type ACTIVE_COMPARATOR

Local block

Intervention Type PROCEDURE

See control and study arm group descriptions for the local block

Study

Will receive an erector spinae block prior to surgery using 30-45 mL of 0.25 bupivacaine w/ epinephrine and 5 mL of dexmedetomidine. Will be administered 30 mL of 0.5% marcaine w/ epinephrine as a local block at the surgical site at the conclusion of the procedure.

Group Type EXPERIMENTAL

Erector spinae block

Intervention Type PROCEDURE

See experimental arm group description

Local block

Intervention Type PROCEDURE

See control and study arm group descriptions for the local block

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erector spinae block

See experimental arm group description

Intervention Type PROCEDURE

Local block

See control and study arm group descriptions for the local block

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients undergoing hip arthroscopy for femoroacetabular impingement
* Ages 13-50
* Individuals who have the capacity to provide consent or assent for themselves

Exclusion Criteria

* Hip arthroscopy for any other reason (not undergoing labral repair, acetabuloplasty, and femoral osteochondroplasty)
* Revision surgery
* Known narcotic use in the 6 months prior to surgery
* Workman's compensation patient
* Pregnancy
Minimum Eligible Age

13 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Carilion Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Benjamin Coobs, MD

Role: PRINCIPAL_INVESTIGATOR

Carilion Clinic Ortho Surgeon

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute for Orthopedics and Neurosciences

Roanoke, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Benjamin Coobs, MD

Role: CONTACT

(540) 521-3830

Daniel Sveom

Role: CONTACT

(540) 981-8050

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-21-1223

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.